25 XP   0   0   10

Novacyt
Buy, Hold or Sell?

Let's analyse Novacyt together

PenkeI guess you are interested in Novacyt. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Novacyt. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Novacyt

I send you an email if I find something interesting about Novacyt.

Quick analysis of Novacyt (30 sec.)










What can you expect buying and holding a share of Novacyt? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p151.94
Expected worth in 1 year
p137.02
How sure are you?
32.3%

+ What do you gain per year?

Total Gains per Share
p-14.93
Return On Investment
-21.9%

For what price can you sell your share?

Current Price per Share
p68.00
Expected price per share
p47.00 - p82.40
How sure are you?
50%

1. Valuation of Novacyt (5 min.)




Live pricePrice per Share (EOD)

p68.00

2. Growth of Novacyt (5 min.)




Is Novacyt growing?

Current yearPrevious yearGrowGrow %
How rich?$134.6m$81.4m$8.8m9.8%

How much money is Novacyt making?

Current yearPrevious yearGrowGrow %
Making money-$53.5k-$123k$69.4k129.5%
Net Profit Margin-164.6%-107.1%--

How much money comes from the company's main activities?

3. Financial Health of Novacyt (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#123 / 332

Most Revenue
#143 / 332

Most Profit
#302 / 332

Most Efficient
#243 / 332

What can you expect buying and holding a share of Novacyt? (5 min.)

Welcome investor! Novacyt's management wants to use your money to grow the business. In return you get a share of Novacyt.

What can you expect buying and holding a share of Novacyt?

First you should know what it really means to hold a share of Novacyt. And how you can make/lose money.

Speculation

The Price per Share of Novacyt is p68.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Novacyt.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Novacyt, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p151.94. Based on the TTM, the Book Value Change Per Share is p-3.73 per quarter. Based on the YOY, the Book Value Change Per Share is p-9.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Novacyt.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%-0.010.0%
Usd Book Value Change Per Share0.000.0%-0.05-0.1%-0.12-0.2%0.100.1%0.060.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.05-0.1%-0.12-0.2%0.100.1%0.060.1%
Usd Price Per Share0.77-0.65-1.76-2.87-1.86-
Price to Earnings Ratio0.00--132.47--479.32-148.06-43.53-
Price-to-Total Gains Ratio-0.05--0.06--160.83-2,923.88-
Price to Book Ratio0.40-11.01-31.43-187.16-124.05-
Price-to-Total Gains Ratio-0.05--0.06--160.83-2,923.88-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.853128
Number of shares1172
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.10
Usd Total Gains Per Share-0.050.10
Gains per Quarter (1172 shares)-54.87117.36
Gains per Year (1172 shares)-219.46469.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-219-2290469459
20-439-4480939928
30-658-667014081397
40-878-886018781866
50-1097-1105023472335
60-1317-1324028172804
70-1536-1543032863273
80-1756-1762037563742
90-1975-1981042254211
100-2195-2200046954680

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.02.01.00.0%2.08.01.018.2%6.012.01.031.6%6.024.01.019.4%6.024.01.019.4%
Book Value Change Per Share1.01.01.033.3%3.03.05.027.3%6.05.08.031.6%10.010.011.032.3%10.010.011.032.3%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share1.01.01.033.3%3.03.05.027.3%6.05.08.031.6%10.010.011.032.3%10.010.011.032.3%

Fundamentals of Novacyt

About Novacyt

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

Fundamental data was last updated by Penke on 2024-04-23 11:56:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Novacyt.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novacyt earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novacyt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-164.6%+164.6%
TTM-164.6%YOY-107.1%-57.5%
TTM-164.6%5Y-49.9%-114.7%
5Y-49.9%10Y-39.2%-10.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.1%+15.1%
TTM-164.6%-20.4%-144.2%
YOY-107.1%-13.3%-93.8%
5Y-49.9%-20.4%-29.5%
10Y-39.2%-27.3%-11.9%
1.1.2. Return on Assets

Shows how efficient Novacyt is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • 0.0% Return on Assets means that Novacyt generated 0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novacyt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.0%+1.0%
TTM-1.0%YOY-2.7%+1.6%
TTM-1.0%5Y-105.4%+104.4%
5Y-105.4%10Y-66.1%-39.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.0%+4.0%
TTM-1.0%-4.5%+3.5%
YOY-2.7%-4.3%+1.6%
5Y-105.4%-3.8%-101.6%
10Y-66.1%-4.8%-61.3%
1.1.3. Return on Equity

Shows how efficient Novacyt is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • 0.0% Return on Equity means Novacyt generated 0.00 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novacyt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.3%+1.3%
TTM-1.3%YOY-3.3%+2.0%
TTM-1.3%5Y-229.1%+227.8%
5Y-229.1%10Y-141.8%-87.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.2%+4.2%
TTM-1.3%-5.6%+4.3%
YOY-3.3%-5.3%+2.0%
5Y-229.1%-6.1%-223.0%
10Y-141.8%-6.7%-135.1%

1.2. Operating Efficiency of Novacyt.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novacyt is operating .

  • Measures how much profit Novacyt makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novacyt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-131.8%+131.8%
TTM-131.8%YOY-56.0%-75.8%
TTM-131.8%5Y-29.9%-102.0%
5Y-29.9%10Y-24.1%-5.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.6%+24.6%
TTM-131.8%-16.7%-115.1%
YOY-56.0%-12.3%-43.7%
5Y-29.9%-19.9%-10.0%
10Y-24.1%-25.7%+1.6%
1.2.2. Operating Ratio

Measures how efficient Novacyt is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.159-2.159
TTM2.159YOY1.060+1.099
TTM2.1595Y0.807+1.352
5Y0.80710Y0.917-0.110
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.430-1.430
TTM2.1591.426+0.733
YOY1.0601.390-0.330
5Y0.8071.416-0.609
10Y0.9171.375-0.458

1.3. Liquidity of Novacyt.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novacyt is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.00 means the company has 0.00 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.393-3.393
TTM3.393YOY4.957-1.564
TTM3.3935Y3.211+0.182
5Y3.21110Y2.407+0.804
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.688-2.688
TTM3.3932.724+0.669
YOY4.9573.429+1.528
5Y3.2113.619-0.408
10Y2.4073.507-1.100
1.3.2. Quick Ratio

Measures if Novacyt is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Quick Ratio of 0.00 means the company can pay off 0.00 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.148-3.148
TTM3.148YOY3.028+0.120
TTM3.1485Y2.085+1.063
5Y2.08510Y1.418+0.666
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.521-1.521
TTM3.1481.671+1.477
YOY3.0282.113+0.915
5Y2.0852.316-0.231
10Y1.4182.425-1.007

1.4. Solvency of Novacyt.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novacyt assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novacyt to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.19 means that Novacyt assets are financed with 18.8% credit (debt) and the remaining percentage (100% - 18.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novacyt:

  • The MRQ is 0.188. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.188. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.188TTM0.188+0.000
TTM0.188YOY0.203-0.015
TTM0.1885Y0.310-0.122
5Y0.31010Y0.318-0.008
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1880.399-0.211
TTM0.1880.390-0.202
YOY0.2030.348-0.145
5Y0.3100.442-0.132
10Y0.3180.458-0.140
1.4.2. Debt to Equity Ratio

Measures if Novacyt is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Debt to Equity ratio of 23.1% means that company has 0.23 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novacyt:

  • The MRQ is 0.231. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.231. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.231TTM0.231+0.000
TTM0.231YOY0.256-0.024
TTM0.2315Y0.502-0.271
5Y0.50210Y0.487+0.015
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2310.576-0.345
TTM0.2310.562-0.331
YOY0.2560.497-0.241
5Y0.5020.626-0.124
10Y0.4870.696-0.209

2. Market Valuation of Novacyt

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Novacyt generates.

  • Above 15 is considered overpriced but always compare Novacyt to the Medical Devices industry mean.
  • A PE ratio of 0.00 means the investor is paying 0.00 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-132.474+132.474
TTM-132.474YOY-479.319+346.846
TTM-132.4745Y148.061-280.535
5Y148.06110Y43.526+104.535
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.794+1.794
TTM-132.474-2.279-130.195
YOY-479.319-2.674-476.645
5Y148.061-2.530+150.591
10Y43.526-2.057+45.583
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-146.551+146.551
TTM-146.551YOY-411.137+264.587
TTM-146.5515Y-192.797+46.246
5Y-192.79710Y-119.635-73.161
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.662+1.662
TTM-146.551-3.006-143.545
YOY-411.137-6.187-404.950
5Y-192.797-4.921-187.876
10Y-119.635-5.292-114.343
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novacyt is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.40 means the investor is paying 0.40 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Novacyt:

  • The EOD is 0.448. Based on the equity, the company is cheap. +2
  • The MRQ is 0.405. Based on the equity, the company is cheap. +2
  • The TTM is 11.011. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.448MRQ0.405+0.043
MRQ0.405TTM11.011-10.606
TTM11.011YOY31.433-20.422
TTM11.0115Y187.160-176.149
5Y187.16010Y124.051+63.109
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.4481.999-1.551
MRQ0.4052.384-1.979
TTM11.0112.530+8.481
YOY31.4333.169+28.264
5Y187.1603.955+183.205
10Y124.0514.369+119.682
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Novacyt compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----3.7310%-9.4150%7.982-100%4.901-100%
Book Value Per Share--151.941101.870+49%91.922+65%48.911+211%36.220+319%
Current Ratio---3.393-100%4.957-100%3.211-100%2.407-100%
Debt To Asset Ratio--0.1880.188+0%0.203-8%0.310-39%0.318-41%
Debt To Equity Ratio--0.2310.231+0%0.256-9%0.502-54%0.487-53%
Dividend Per Share----0%-0%-0%-0%
Eps----0.0390%-0.0910%-0.3760%-0.5670%
Gross Profit Margin---0.764-100%1.016-100%0.966-100%0.915-100%
Market Cap4802581600.000+10%4343514252.0003659616750.533+19%9918750269.120-56%16128469569.352-73%10486652858.635-59%
Net Profit Margin----1.6460%-1.0710%-0.4990%-0.3920%
Operating Margin----1.3180%-0.5600%-0.2990%-0.2410%
Operating Ratio---2.159-100%1.060-100%0.807-100%0.917-100%
Pb Ratio0.448+10%0.40511.011-96%31.433-99%187.160-100%124.051-100%
Pe Ratio----132.4740%-479.3190%148.061-100%43.526-100%
Price Per Share68.000+10%61.50051.817+19%140.440-56%228.364-73%148.481-59%
Price To Free Cash Flow Ratio----146.5510%-411.1370%-192.7970%-119.6350%
Quick Ratio---3.148-100%3.028-100%2.085-100%1.418-100%
Return On Assets----0.0100%-0.0270%-1.0540%-0.6610%
Return On Equity----0.0130%-0.0330%-2.2910%-1.4180%
Total Gains Per Share----3.7310%-9.4150%7.982-100%4.901-100%
Usd Book Value--134631126.00090264479.452+49%81449993.241+65%43339199.917+211%32093794.941+319%
Usd Book Value Change Per Share----0.0470%-0.1180%0.100-100%0.061-100%
Usd Book Value Per Share--1.9061.278+49%1.153+65%0.614+211%0.454+319%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.0000%-0.0010%-0.0050%-0.0070%
Usd Free Cash Flow----33674.8280%-43279.6790%-14893.7820%-162763.1210%
Usd Market Cap60253188.754+10%54493729.80645913551.752+19%124440640.876-56%202347779.217-73%131565546.764-59%
Usd Price Per Share0.853+10%0.7720.650+19%1.762-56%2.865-73%1.863-59%
Usd Profit----53592.0870%-123016.4880%-262743.4640%-458574.2170%
Usd Revenue--104099.20556334.087+85%67486.383+54%1120883.243-91%1579752.555-93%
Usd Total Gains Per Share----0.0470%-0.1180%0.100-100%0.061-100%
 EOD+3 -2MRQTTM+9 -6YOY+9 -65Y+9 -1110Y+9 -11

3.2. Fundamental Score

Let's check the fundamental score of Novacyt based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Book Ratio (EOD)Between0-10.448
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than10.188
Debt to Equity Ratio (MRQ)Less than10.231
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total3/9 (33.3%)

3.3. Technical Score

Let's check the technical score of Novacyt based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.023
Ma 20Greater thanMa 5062.878
Ma 50Greater thanMa 10052.088
Ma 100Greater thanMa 20053.582
OpenGreater thanClose69.800
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Current Assets
Cash And Cash Equivalents 44,126
Other Current Assets -44,126
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Cash and Short Term Investments 44,126
Net Debt -44,126



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312015-06-302014-12-312014-06-30
> Total Assets 
26,566
26,588
24,946
17,106
29,932
30,442
30,442
31,341
31,341
34,024
34,024
34,748
34,750
32,513
32,513
34,122
34,122
0
26,540
0
80,383
0
234,276
0
182,177
0
183,697
0
166,128
0
140,901
150,295
132,148
0
0132,148150,295140,9010166,1280183,6970182,1770234,276080,383026,540034,12234,12232,51332,51334,75034,74834,02434,02431,34131,34130,44230,44229,93217,10624,94626,58826,566
   > Total Current Assets 
5,359
6,070
5,256
5,609
6,641
7,360
7,360
8,478
8,478
10,908
10,908
10,073
10,074
10,010
10,009
9,564
9,564
6,902
5,897
64,839
59,244
204,985
204,985
152,928
152,928
158,783
158,783
142,078
142,078
127,238
127,238
136,316
119,857
0
0119,857136,316127,238127,238142,078142,078158,783158,783152,928152,928204,985204,98559,24464,8395,8976,9029,5649,56410,00910,01010,07410,07310,90810,9088,4788,4787,3607,3606,6415,6095,2566,0705,359
       Cash And Cash Equivalents 
1,409
2,326
1,322
527
1,743
2,843
2,856
2,577
2,577
4,345
4,345
2,134
2,134
1,132
1,132
598
598
0
1,542
0
18,018
0
91,765
0
77,204
0
101,746
0
99,641
0
86,973
92,958
81,734
44,126
44,12681,73492,95886,973099,6410101,746077,204091,765018,01801,54205985981,1321,1322,1342,1344,3454,3452,5772,5772,8562,8431,7435271,3222,3261,409
       Short-term Investments 
160
10
10
1,164
23
23
10
10
10
10
10
22
22
10
10
10
10
0
9
0
9
0
9
0
9
0
9
0
9
0
9
10
9
0
091090909090909090101010102222101010101023231,1641010160
       Net Receivables 
0
0
0
0
0
2,567
2,567
3,255
3,255
4,075
4,075
4,355
4,355
3,994
3,994
3,708
3,573
2,172
2,172
28,470
28,470
79,592
79,592
58,295
58,295
43,533
30,190
36,293
36,302
34,811
34,721
28,389
33,927
0
033,92728,38934,72134,81136,30236,29330,19043,53358,29558,29579,59279,59228,47028,4702,1722,1723,5733,7083,9943,9944,3554,3554,0754,0753,2553,2552,5672,56700000
       Inventory 
1,229
1,337
1,298
1,488
1,800
1,614
1,614
1,810
1,810
1,942
1,942
3,113
3,114
2,347
2,347
2,356
2,356
2,439
2,084
15,558
14,215
29,888
29,888
15,127
15,127
11,461
11,461
4,255
4,255
3,027
3,027
2,797
2,459
0
02,4592,7973,0273,0274,2554,25511,46111,46115,12715,12729,88829,88814,21515,5582,0842,4392,3562,3562,3472,3473,1143,1131,9421,9421,8101,8101,6141,6141,8001,4881,2981,3371,229
   > Long-term Assets 
21,207
20,518
19,690
11,497
23,290
0
23,082
0
22,863
0
23,116
0
24,676
0
22,503
0
24,558
0
20,643
0
21,139
0
29,291
0
29,249
0
24,914
0
24,050
0
13,663
13,979
12,291
0
012,29113,97913,663024,050024,914029,249029,291021,139020,643024,558022,503024,676023,116022,863023,082023,29011,49719,69020,51821,207
       Property Plant Equipment 
372
533
669
683
1,172
1,096
1,096
1,112
1,112
1,573
1,573
1,561
1,561
1,191
1,191
3,752
3,752
3,478
2,971
3,221
2,943
3,902
3,902
5,126
5,126
6,382
6,382
3,991
3,991
3,272
3,272
2,960
2,603
0
02,6032,9603,2723,2723,9913,9916,3826,3825,1265,1263,9023,9022,9433,2212,9713,4783,7523,7521,1911,1911,5611,5611,5731,5731,1121,1121,0961,0961,172683669533372
       Goodwill 
0
0
0
0
0
16,466
16,466
16,466
16,466
16,466
16,466
18,212
18,213
16,134
16,134
15,913
15,913
0
13,599
0
14,538
0
17,877
0
17,457
0
11,471
0
11,638
0
6,646
7,372
6,482
0
06,4827,3726,646011,638011,471017,457017,877014,538013,599015,91315,91316,13416,13418,21318,21216,46616,46616,46616,46616,46616,46600000
       Long Term Investments 
0
0
0
0
0
0
0
4
4
4
4
247
247
4
4
228
228
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002282284424724744440000000
       Intangible Assets 
0
0
0
0
0
5,146
5,333
4,888
4,888
4,701
4,840
4,656
4,656
4,944
4,884
4,664
4,664
0
3,685
0
3,211
0
4,255
0
3,901
0
3,710
0
3,429
0
3,121
3,047
2,679
0
02,6793,0473,12103,42903,71003,90104,25503,21103,68504,6644,6644,8844,9444,6564,6564,8404,7014,8884,8885,3335,14600000
       Long-term Assets Other 
166
19
25
1,274
107
0
180
0
38
0
235
0
50
0
293
0
34
0
381
0
355
0
229
0
113
0
73
0
73
0
730
599
613
0
0613599730073073011302290355038103402930500235038018001071,2742519166
> Total Liabilities 
5,822
6,061
5,069
6,582
13,262
12,673
12,674
11,522
11,522
9,110
9,110
11,730
11,731
12,375
12,375
15,637
15,638
0
14,072
0
26,692
0
83,566
0
43,626
0
41,882
0
33,461
0
25,685
28,249
24,838
0
024,83828,24925,685033,461041,882043,626083,566026,692014,072015,63815,63712,37512,37511,73111,7309,1109,11011,52211,52212,67412,67313,2626,5825,0696,0615,822
   > Total Current Liabilities 
4,533
4,692
3,779
4,335
8,320
8,816
8,817
8,096
8,096
7,783
7,784
8,199
8,198
9,895
9,895
11,576
11,576
7,689
5,849
26,877
24,558
74,142
74,142
34,272
34,272
38,904
38,904
30,467
30,467
24,236
24,236
26,785
23,551
0
023,55126,78524,23624,23630,46730,46738,90438,90434,27234,27274,14274,14224,55826,8775,8497,68911,57611,5769,8959,8958,1988,1997,7847,7838,0968,0968,8178,8168,3204,3353,7794,6924,533
       Short-term Debt 
160
10
10
1,164
23
8,847
10
8,050
10
2,778
10
3,099
22
3,115
10
4,656
10
0
1,379
0
206
0
414
0
365
0
424
0
347
0
609
0
170
0
017006090347042403650414020601,3790104,656103,115223,099102,778108,050108,847231,1641010160
       Short Long Term Debt 
0
0
0
0
0
8,847
8,847
8,050
8,050
2,778
2,778
3,099
3,099
3,115
3,115
4,656
4,656
0
2,190
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002,19004,6564,6563,1153,1153,0993,0992,7782,7788,0508,0508,8478,84700000
       Accounts payable 
0
0
0
0
0
2,087
2,087
1,922
1,922
1,745
1,745
3,390
3,390
2,769
2,769
4,972
4,972
2,091
1,786
3,572
3,264
5,228
5,228
1,587
1,587
1,363
1,363
914
914
2,787
278
403
354
0
03544032782,7879149141,3631,3631,5871,5875,2285,2283,2643,5721,7862,0914,9724,9722,7692,7693,3903,3901,7451,7451,9221,9222,0872,08700000
       Other Current Liabilities 
0
0
0
0
0
1,159
1,159
1,112
1,112
2,707
2,707
1,710
1,710
3,713
3,713
1,742
1,347
2,668
2,683
13,754
21,088
50,587
68,500
31,297
6,843
36,048
12,558
27,631
29,206
20,840
22,810
26,382
418
0
041826,38222,81020,84029,20627,63112,55836,0486,84331,29768,50050,58721,08813,7542,6832,6681,3471,7423,7133,7131,7101,7102,7072,7071,1121,1121,1591,15900000
   > Long-term Liabilities 
1,289
1,369
1,290
2,247
4,942
0
3,857
0
3,426
0
1,326
0
3,533
0
2,480
0
4,062
0
8,223
0
2,134
0
9,424
0
9,354
0
2,978
0
2,994
0
1,449
1,464
1,287
0
01,2871,4641,44902,99402,97809,35409,42402,13408,22304,06202,48003,53301,32603,42603,85704,9422,2471,2901,3691,289
       Other Liabilities 
0
0
0
0
0
155
155
102
102
212
212
332
332
221
221
231
231
289
289
293
293
7,460
7,460
7,647
7,647
1,532
1,532
1,670
1,670
1,186
1,186
1,068
1,068
0
01,0681,0681,1861,1861,6701,6701,5321,5327,6477,6477,4607,46029329328928923123122122133233221221210210215515500000
       Deferred Long Term Liability 
0
0
0
0
0
187
187
162
162
139
139
0
0
0
0
0
0
306
306
0
0
124
124
0
0
69
69
0
0
0
0
0
0
0
00000006969001241240030630600000013913916216218718700000
> Total Stockholder Equity
0
0
0
0
0
17,769
17,769
19,819
19,819
24,914
24,914
23,018
23,018
20,138
20,138
18,485
18,484
0
12,468
0
53,691
0
150,710
0
138,551
0
141,815
0
132,667
0
115,216
122,046
107,310
0
0107,310122,046115,2160132,6670141,8150138,5510150,710053,691012,468018,48418,48520,13820,13823,01823,01824,91424,91419,81919,81917,76917,76900000
   Common Stock
0
0
0
0
0
1,161
1,161
1,472
1,472
2,511
2,511
2,511
2,511
2,511
2,511
2,710
2,710
3,873
3,309
4,708
4,302
4,053
4,053
4,053
4,053
4,053
4,053
4,053
4,053
4,053
4,053
4,610
4,053
0
04,0534,6104,0534,0534,0534,0534,0534,0534,0534,0534,0534,0534,3024,7083,3093,8732,7102,7102,5112,5112,5112,5112,5112,5111,4721,4721,1611,16100000
   Retained Earnings 
-566
-3,702
-2,698
-22,157
-28,406
-30,470
-27,867
-32,174
-32,174
-33,309
-33,309
-35,153
-35,153
-38,047
-38,047
-39,924
-39,924
-44,212
-37,772
-4,017
-3,670
96,916
96,916
84,241
84,241
87,188
87,188
78,488
78,488
61,445
61,445
60,388
53,097
0
053,09760,38861,44561,44578,48878,48887,18887,18884,24184,24196,91696,916-3,670-4,017-37,772-44,212-39,924-39,924-38,047-38,047-35,153-35,153-33,309-33,309-32,174-32,174-27,867-30,470-28,406-22,157-2,698-3,702-566
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,866
0
60,866
0
0
0
0
0
0
0
0
0
00000000060,866060,8660000000000000000000000
   Treasury Stock000000000-760-590000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
123
123
116
116
-2,393
-2,393
-2,397
-2,397
-2,397
-2,397
-2,171
55,698
-2,905
48,824
-3,942
53,060
-881
49,741
-351
50,257
-19
50,574
-453
50,126
-862
49,718
57,489
50,160
0
050,16057,48949,718-86250,126-45350,574-1950,257-35149,741-88153,060-3,94248,824-2,90555,698-2,171-2,397-2,397-2,397-2,397-2,393-2,39311611612312300000



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue11,564
Cost of Revenue--
Gross Profit11,56411,564
 
Operating Income (+$)
Gross Profit11,564
Operating Expense--
Operating Income11,56411,564
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income11,564
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-11,564
EBIT - interestExpense = 0
0
0
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-0
Earnings Before Interest and Taxes (EBITDA)11,564
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Novacyt
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Novacyt. The general trend of Novacyt is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Novacyt's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Novacyt.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 74.05 < 77.87 < 82.40.

The bearish price targets are: 68.00 > 55.13 > 47.00.

Tweet this
Novacyt Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Novacyt. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Novacyt Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Novacyt. The current macd is 5.94749298.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Novacyt price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Novacyt. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Novacyt price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Novacyt Daily Moving Average Convergence/Divergence (MACD) ChartNovacyt Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Novacyt. The current adx is 58.71.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Novacyt shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Novacyt Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Novacyt. The current sar is 82.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Novacyt Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Novacyt. The current rsi is 64.02. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Novacyt Daily Relative Strength Index (RSI) ChartNovacyt Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Novacyt. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Novacyt price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Novacyt Daily Stochastic Oscillator ChartNovacyt Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Novacyt. The current cci is 48.04.

Novacyt Daily Commodity Channel Index (CCI) ChartNovacyt Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Novacyt. The current cmo is 18.85.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Novacyt Daily Chande Momentum Oscillator (CMO) ChartNovacyt Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Novacyt. The current willr is -49.57507082.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Novacyt is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Novacyt Daily Williams %R ChartNovacyt Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Novacyt.

Novacyt Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Novacyt. The current atr is 5.33332254.

Novacyt Daily Average True Range (ATR) ChartNovacyt Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Novacyt. The current obv is 5,977,216.

Novacyt Daily On-Balance Volume (OBV) ChartNovacyt Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Novacyt. The current mfi is 69.97.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Novacyt Daily Money Flow Index (MFI) ChartNovacyt Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Novacyt.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside

6.3. Candlestick Patterns

Novacyt Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Novacyt based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.023
Ma 20Greater thanMa 5062.878
Ma 50Greater thanMa 10052.088
Ma 100Greater thanMa 20053.582
OpenGreater thanClose69.800
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Novacyt with someone you think should read this too:
  • Are you bullish or bearish on Novacyt? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Novacyt? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Novacyt

I send you an email if I find something interesting about Novacyt.


Comments

How you think about this?

Leave a comment

Stay informed about Novacyt.

Receive notifications about Novacyt in your mailbox!